Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: ROR1 and ROR2 expression in pancreatic cancer

Fig. 2

Association between ROR1 mRNA/protein expression level and clinicopathological parameters in the ICGC-PACA-AU, TCGA-PAAD and CPTAC-PDAC cohorts. A. No significant difference of ROR1 expression was observed between low and high tumour grade. B. ROR1 expression was associated with stage in ICGC-PACA-AU and TCGA-PAAD cohorts in opposite directions (p = 0.033 and 0.036 respectively). No significant correlation between ROR1 mRNA and stage was observed in CPTAC-PDAC cohort. C. High ROR1 mRNA expression level was associated with better overall survival (p < 0.001) in the ICGC-PACA-AU cohort. D. High ROR1 mRNA expression was associated with better overall survival (p = 0.045) in the TCGA-PAAD cohort. E. High ROR1 mRNA expression was associated with better overall survival (p = 0.026) in the CPTAC-PDAC cohort. F. ROR1 protein expression was not associated with overall survival in the CPTAC-PDAC cohort. *Significance at p < 0.05 level

Back to article page